Izadiyan Z, Misran M, Kalantari K, Webster T, Kia P, Basrowi N
Int J Nanomedicine. 2025; 20:1213-1262.
PMID: 39911259
PMC: 11794392.
DOI: 10.2147/IJN.S488961.
Ragab E, El Gamal D, El-Najjar F, Elkomy H, Ragab M, Elantary M
Discov Oncol. 2025; 16(1):107.
PMID: 39891818
PMC: 11787125.
DOI: 10.1007/s12672-025-01846-3.
Mohammad-Jafari K, Naghib S, Mozafari M
Curr Pharm Des. 2024; 30(36):2850-2881.
PMID: 39051580
DOI: 10.2174/0113816128304923240704113319.
Yang G, Liu Y, Hu Y, Yuan Y, Qin Y, Li Q
J Pharm Anal. 2024; 14(6):100943.
PMID: 39005842
PMC: 11246065.
DOI: 10.1016/j.jpha.2024.01.011.
Cheung E, Xia Y, Caporini M, Gilmore J
Biophys Rev (Melville). 2024; 3(3):031301.
PMID: 38505278
PMC: 10903431.
DOI: 10.1063/5.0087583.
Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats.
Bahri S, Abdollahizad E, Mahlooji I, Rezaee E, Abbasian Z, Dadashzadeh S
Iran J Pharm Res. 2024; 22(1):e138362.
PMID: 38444706
PMC: 10912895.
DOI: 10.5812/ijpr-138362.
Predicting intratumoral fluid pressure and liposome accumulation using physics informed deep learning.
Meaney C, Stapleton S, Kohandel M
Sci Rep. 2023; 13(1):20548.
PMID: 37996509
PMC: 10667280.
DOI: 10.1038/s41598-023-47988-8.
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.
Fulton M, Najahi-Missaoui W
Int J Mol Sci. 2023; 24(7).
PMID: 37047585
PMC: 10095497.
DOI: 10.3390/ijms24076615.
Gold cluster encapsulated liposomes: theranostic agent with stimulus triggered release capability.
Amini S, Rezayat S, Dinarvand R, Kharrazi S, Jaafari M
Med Oncol. 2023; 40(5):126.
PMID: 36961614
DOI: 10.1007/s12032-023-01991-1.
Doxorubicin-Loaded Multivesicular Liposomes (DepoFoam) as a Sustained Release Carrier Intended for Locoregional Delivery in Cancer Treatment: Development, Characterization, and Cytotoxicity Evaluation.
Mahjoub M, Dadashzadeh S, Haeri A, Shahhosseini S, Abbasian Z, Nowroozi F
Iran J Pharm Res. 2023; 21(1):e134190.
PMID: 36896322
PMC: 9990514.
DOI: 10.5812/ijpr-134190.
Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors.
Li X, Bo Y, Yin H, Liu X, Li X, Yang F
Front Pharmacol. 2023; 14:1102244.
PMID: 36726585
PMC: 9885713.
DOI: 10.3389/fphar.2023.1102244.
Recent Advances in the Biomedical Applications of Functionalized Nanogels.
Narayanan K, Bhaskar R, Han S
Pharmaceutics. 2022; 14(12).
PMID: 36559325
PMC: 9782855.
DOI: 10.3390/pharmaceutics14122832.
Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review.
Davoudi M, Jadidi Y, Moayedi K, Farrokhi V, Afrisham R
J Nanobiotechnology. 2022; 20(1):504.
PMID: 36457031
PMC: 9714065.
DOI: 10.1186/s12951-022-01718-w.
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment.
Toro-Cordova A, Llaguno-Munive M, Jurado R, Garcia-Lopez P
Pharmaceutics. 2022; 14(11).
PMID: 36432634
PMC: 9697689.
DOI: 10.3390/pharmaceutics14112443.
Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood-Brain Tumour Barrier.
Barzegar-Fallah A, Gandhi K, Rizwan S, Slatter T, Reynolds J
Pharmaceutics. 2022; 14(10).
PMID: 36297666
PMC: 9607160.
DOI: 10.3390/pharmaceutics14102231.
Novel Implications of Nanoparticle-Enhanced Radiotherapy and Brachytherapy: Z-Effect and Tumor Hypoxia.
Zhou R, Zhao D, Beeraka N, Wang X, Lu P, Song R
Metabolites. 2022; 12(10).
PMID: 36295845
PMC: 9612299.
DOI: 10.3390/metabo12100943.
Antitumor Immunotherapy of Sialic Acid and/or GM1 Modified Coenzyme Q10 Submicron Emulsion.
Meng X, Yan N, Guo T, Chen M, Sui D, Wang M
AAPS PharmSciTech. 2022; 23(8):283.
PMID: 36253573
DOI: 10.1208/s12249-022-02426-2.
A mucoadhesive patch loaded with freeze-dried liposomes for the local treatment of oral tumors.
Habib L, Alyan M, Ghantous Y, Shklover J, Shainsky J, Abu El-Naaj I
Drug Deliv Transl Res. 2022; 13(5):1228-1245.
PMID: 36050621
DOI: 10.1007/s13346-022-01224-4.
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.
Rodriguez F, Caruana P, de la Fuente N, Espanol P, Gamez M, Balart J
Biomolecules. 2022; 12(6).
PMID: 35740909
PMC: 9221343.
DOI: 10.3390/biom12060784.
Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics.
Geddie M, Kirpotin D, Kohli N, Kornaga T, Boll B, Razlog M
MAbs. 2022; 14(1):2083466.
PMID: 35708974
PMC: 9225506.
DOI: 10.1080/19420862.2022.2083466.
